---
title: "Centuple Global Ltd (531099) — Share Price, Financials & Analysis"
symbol: "531099"
company: "Centuple Global Ltd"
canonical: "https://tapetide.com/stocks/531099"
isin: "INE396H01019"
nse_symbol: "RUBRAMEDICAMENTSLTD"
bse_code: "531099"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 18.72
generated_at: "2026-09-13T19:16:37.990Z"
---

# Centuple Global Ltd (531099)

Canonical page: https://tapetide.com/stocks/531099

## Company

- **NSE Symbol:** RUBRAMEDICAMENTSLTD
- **BSE Code:** 531099
- **ISIN:** INE396H01019
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** rubramed.com

## About

Incorporated in 1991, Checkpoint Trends Ltd is in the business of trading and consultancy[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:39:02.518480Z.

- **Market Cap:** ₹18.72 Cr
- **Classification:** Microcap
- **P/E (reported):** 15.9
- **EPS (TTM):** ₹2.24
- **EPS (reported):** ₹0.06
- **Book Value:** ₹42.47
- **Price to Book:** 0.85
- **Dividend Yield:** 0%
- **ROE:** 4.55%
- **ROCE:** 8.58%
- **Debt to Equity:** 0.3
- **Revenue (yearly):** ₹573.81 Cr
- **Net Income:** ₹1.5 Cr
- **EBITDA:** ₹2.28 Cr
- **52-Week High:** ₹144.4
- **52-Week Low:** ₹31.62
- **RSI (14):** 46.23

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-08-26
- **Percentile:** 44 (of 4468 scored stocks)
- **Confidence:** 82%
- **Data coverage:** 81%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 20.86 | 10.23% |
| growth | 98.9 | 10.23% |
| ownership | 33.7 | 27.27% |
| quality | 33.37 | 25% |
| valuation | 72.72 | 27.27% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Stock is trading at 0.82 times its book value
- Company's median sales growth is 26.2% of last 10 years
- Company's working capital requirements have reduced from 182 days to 14.7 days

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 12.3% over last 3 years.
- Company might be capitalizing the interest cost
- Company has high debtors of 215 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 0.19% | — | -63.46% |
| ebitda margin growth | 50% | -96.4% | -84.73% | -139.22% |
| net income growth | 60% | — | 175% | 173% |
| revenue growth | -100% | — | 691% | 311% |
| roce | — | 102.36% | -153.52% | -1.13% |
| roe | — | -19.75% | -1.8% | 400% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 0.29 | 0.17 | 0.47 | 0.1 | 0.05 | 0.1 | 0.25 | 11.71 | 108.59 | 174.09 | 279.41 | 0 |
| Expenses | 0.03 | 0.11 | 0.71 | 0.07 | 0.08 | 0.14 | 0.16 | 11.62 | 106.79 | 173.32 | 279.78 | 0.18 |
| Operating Profit | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.04 | 0.09 | 0.09 | 1.8 | 0.77 | -0.37 | -0.18 |
| OPM % | 89.66 | 35.29 | -51.06 | 30 | -60 | -40 | 36 | 0.77 | 1.66 | 0.44 | -0.13 | — |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0.02 | -0.02 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.26 | 0.06 | -0.24 | 0.03 | -0.03 | -0.02 | 0.07 | 0.09 | 1.8 | 0.77 | -0.37 | -0.18 |
| Tax % | 0 | 0 | -4.17 | 0 | 33.33 | 0 | 0 | 0 | 26.11 | 25.97 | 27.03 | 0 |
| Net Profit | 0.26 | 0.06 | -0.23 | 0.02 | -0.04 | -0.02 | 0.06 | 0.09 | 1.32 | 0.57 | -0.48 | -0.18 |
| EPS in Rs | 0.48 | 0.11 | -0.42 | 0.04 | -0.07 | -0.04 | 0.11 | 0.16 | 2.41 | 1.04 | -0.88 | -0.33 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 574 | 562 |
| Expenses | 2 | 1 | 1 | 0 | 2 | 1 | 1 | 0 | 572 | 560 |
| Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| OPM % | -1.3 | -31 | 2 | 2 | -1 | -7 | 2.6 | 20 | 0.4 | 0.4 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 |
| Tax % | 0 | 0 | 20 | 0 | 50 | 0 | -50 | 40 | 34 | — |
| Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 |
| EPS in Rs | -0.29 | -0.02 | 0.05 | 0.02 | -0.07 | -0.15 | 0.05 | 0.05 | 2.76 | 2.24 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | -5 | 18 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 |
| Other Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 313 |
| Total Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 343 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 343 |
| Total Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 343 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -28 |
| Cash from Investing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing Activity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Free Cash Flow | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | -28 |
| CFO/OP | 133 | -600 | 17 | 650 | 5200 | 2450 | -12 | 0 | 190 | -1223 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 24 | 54 | 179 | 107 | 164 | 122 | 135 | 229 | 212 | 215 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | — | — | — | 1 |
| Days Payable | — | — | — | — | — | — | — | — | — | 197 |
| Cash Conversion Cycle | 24 | 54 | 179 | 107 | 164 | 122 | 135 | 229 | 212 | 19 |
| Working Capital Days | -35 | 36 | 260 | 221 | 60 | 98 | 129 | 145 | 387 | 15 |
| ROCE % | 7 | 25 | -31 | 3 | 2 | -3 | -13 | 3 | 17 | 15 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 10.85% | 10.86% | 10.86% | 10.71% | 8.59% | 11.15% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 89.85% | 89.9% | 90.38% | 91.05% | 88.12% | 87.09% | 71.77% | 70.2% | 73.69% | 75.24% | 77.08% | 74.67% |
| Others | 10.15% | 10.1% | 9.62% | 8.95% | 11.88% | 12.91% | 17.37% | 18.94% | 15.46% | 14.05% | 14.32% | 14.18% |
| No. of Shareholders | 1712 | 1722 | 1981 | 2039 | 2073 | 2123 | 2204 | 2277 | 2416 | 2396 | 2457 | 2429 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 0 / 7 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 35.61 | Sell |
| EMA (10) | 35.86 | Sell |
| SMA (20) | 36.4 | Sell |
| EMA (20) | 36.88 | Sell |
| SMA (50) | 38.06 | Sell |
| EMA (50) | 38.7 | Sell |
| SMA (100) | 40.62 | Sell |
| EMA (100) | 43.76 | Sell |
| SMA (200) | 65.58 | Sell |
| EMA (200) | 49.08 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.08 | Neutral |
| MACD (12,26,9) | -1.2 | Sell |
| Stochastic (14,3,3) | 34.94 | Neutral |
| ADX (14) | 14.33 | Neutral |
| Williams %R (14) | -71.11 | Neutral |
| ATR (14) | 3.12 | High Volatility |
| ROC (12) | -9.86 | Sell |
| Stoch RSI (14) | 33.77 | Neutral |
| UO (7,14,28) | 58.01 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-08 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea266791-811a-49e4-91e4-ea1515d3dcb8.pdf) |
| 2026-09-05 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a86a2e70-1e19-49e9-860e-8ea0008a514f.pdf) |
| 2026-09-05 | [Notice Of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ff9c5bd-4028-4e57-b3da-e739d6bd8464.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c21e9e6d-5036-4e39-90e9-67565fc7240d.pdf) |
| 2026-08-27 | [Board Meeting Intimation for Intimation Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=61deea0c-1119-4bca-a1dc-1f5dd5d5e8ca.pdf) |
| 2026-08-27 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaa076b0-49ce-49fe-910e-d02e41942359.pdf) |
| 2026-08-26 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24b7d812-5f24-48d9-8a44-206dc24373c4.pdf) |
| 2026-08-18 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4210b0a7-e240-42e1-bc98-bd087b79cb45.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Resignation of Statutory Auditors](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=020b3c23-4360-4b53-ac7f-d302e2f23555.pdf) |
| 2026-08-04 | [Board Meeting Intimation for Intimation Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4679de29-50a4-4a4c-a69d-df18ef174faf.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c596773d-3e8f-4c05-888b-06b45c0f08af.pdf) |
| 2026-05-30 | [Audited Financial Result For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3687d41b-8667-496e-9338-cc1b6c315100.pdf) |
| 2026-01-28 | [Unaudited Result For The Quarter Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89d248c3-194e-4686-abc9-5891730425b0.pdf) |
| 2025-12-26 | [Audited Financial Result For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdfb3120-b067-4af4-9552-bebfb651eb29.pdf) |
| 2025-11-12 | [Unaudited Financial Result For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3436589d-8963-4c43-ac30-fc043da5f131.pdf) |
| 2025-08-06 | [Outcome Of The Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5bc91299-6022-4de0-acae-b37895a73280.pdf) |
| 2024-11-11 | [Outcome Of Board Meeting Alongwith Unaudited Financial Result For The Quarter Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbe2d49a-89f2-4294-b623-086ef9a5484a.pdf) |
| 2024-08-13 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a9415b18-dcbc-41e3-96ba-4e3fee637a8e.pdf) |
| 2024-05-25 | [Audited Financial Result For The Year Ended March 31, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=850bacfb-ee92-473b-b4ec-74b5ef9676fa.pdf) |
| 2024-02-07 | [Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcf69f18-daac-4979-a5e3-df59f6696e87.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Regulation 74(5) confirmation certificate filed for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Regulation 74(5) confirmation certificate filed for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/958e6109-ce0a-48bf-969d-50705785829a.pdf) |
| 5 Mar - Allotted 1,66,74,072 warrants at Rs45.01 each, raising Rs75.05 crore, March 5, 2026. | [Board Meeting Outcome for Subject: Outcome Of The Board Meeting For Allotment Of 1,66,74,072 (One Crores Sixty Six Lakhs Seventy Four Thousand Seventy Two) Convertible Warrants ('Warrants'). 5 Mar - Allotted 1,66,74,072 warrants at Rs45.01 each, raising Rs75.05 crore, March 5, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f67a28cf-4cb5-49d5-9839-1859a921d323.pdf) |
| 5 Mar - Allotment of 1,66,74,072 warrants at ₹45.01 each, raising ₹75.05 crore; 25% received. | [Announcement under Regulation 30 (LODR)-Allotment 5 Mar - Allotment of 1,66,74,072 warrants at ₹45.01 each, raising ₹75.05 crore; 25% received.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/050fa641-8480-433f-9ca5-1710251909c8.pdf) |
| 29 Jan - Corrigendum to the Notice of EGM | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Jan - Corrigendum to the Notice of EGM](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5eddc985-1fb6-4a88-9a49-9cc96afb2806.pdf) |
| 29 Apr - Company confirms it is not a Large Corporate Entity; FY2025-26 debt borrowing was 6.73 crore. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 29 Apr - Company confirms it is not a Large Corporate Entity; FY2025-26 debt borrowing was 6.73 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d33a0074-02ea-4481-a6ab-f8cb9d36d5cf.pdf) |
| 29 Apr - Company confirms it is not a Large Corporate Entity; FY2025-26 debt borrowing was 6.73 crore. | [Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 29 Apr - Company confirms it is not a Large Corporate Entity; FY2025-26 debt borrowing was 6.73 crore.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d33a0074-02ea-4481-a6ab-f8cb9d36d5cf.pdf) |
| 29 Apr - Centuple Global confirms it is not a large corporate; borrowings stood at ₹6.73 crore on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Centuple Global confirms it is not a large corporate; borrowings stood at ₹6.73 crore on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/10e68d2a-0863-4226-b7a5-db2b1c24be98.pdf) |
| 29 Apr - Centuple Global confirms it is not a large corporate; borrowings stood at ₹6.73 crore on March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Centuple Global confirms it is not a large corporate; borrowings stood at ₹6.73 crore on March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/10e68d2a-0863-4226-b7a5-db2b1c24be98.pdf) |
| 25 Feb - Board meeting scheduled February 25, 2026 cancelled; company to inform revised date if any. | [Cancellation Of Board Meeting 25 Feb - Board meeting scheduled February 25, 2026 cancelled; company to inform revised date if any.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3389c471-3b26-490b-94ad-e5cca5ae6c5d.pdf) |
| 24 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for year ending March 31, 2026. | [Closure of Trading Window 24 Mar - Trading window closed from April 1, 2026 until 48 hours after audited results for year ending March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3bfe49c-c1f6-4a5b-9d61-836d56d88c35.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d5ee5a5b-9836-47dd-99a0-65c48146ad17.pdf) |
| Sep 2021 | [Concall - Sep 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6c924a14-ed38-4d6c-a499-bcb8a29d0122.pdf) |
| Sep 2020 | [Concall - Sep 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/beee37d1-0987-4e8d-a68e-3343c352097c.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/9/da77e5d8-ba84-4090-a310-134388462160.pdf) |
| Sep 2018 | [Concall - Sep 2018](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2018/9/48518354-6547-4e65-8dc7-0f14873124b2.pdf) |
| Sep 2017 | [Concall - Sep 2017](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/9/75483d6b-26ed-407d-8f77-27b67a80cb66.pdf) |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2eb875fe-ef79-4b40-88b8-228ccc8be17e.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a208b4bc-a7a8-4ffc-b0f0-00f1f72b4129.pdf) |
| Oct 2023 | [Concall - Oct 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f59b46e-c8fe-4871-b761-98278441c937.pdf) |
| Oct 2022 | [Concall - Oct 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bafbe090-ae6a-4174-a1e6-85350a64b5bd.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/770bf03e-526d-45d8-8364-13f7fc523289.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e3321925-a4f3-4f21-b7aa-d8841a7b5629.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/02d8d87d-90ce-4191-8b3f-4167267aee8a.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/885db65c-4d0c-4906-aa5d-5693af462d5c.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dbf3868a-97f3-43ed-b5ce-47e83261fdc4.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/af1ff0ba-4f47-41b7-ad85-78ddc3ce5d2d.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/500696/73027500696.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/531099/77318531099.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/500696/68482500696.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/531099/70886531099.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:37.990Z.